Importantly, recent data from large longitudinal AD cohorts enrolled in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) suggests that vascular flow abnormalities occur very early in AD and may precede biomarker indicators of amyloid and tau pathology [19]. Here, MAPT is linked to Alzheimer disease.